Sponsors have to explain in their applications why the device constituent part should be included in a DMF and not an IND, NDA, ANDA or BLA. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
